483 Teva Parenteral Manufacturing Feb 2000

483 Teva Parenteral Manufacturing Feb 2000

Walden Lee FDA, Andrew Limson FDA, Caryn Mcnab FDA, Virgilio Pacio FDA$595.00 - Available Now

FDA investigators audited the Teva Parenteral Manufacturing - Irvine, CA, United States facility and issued inspectional observations (via FDA 483) on 25 Feb 2000.

Product details

  • Category: Human Drugs
  • Inspection end: 25 Feb 2000
  • Location: Irvine, United States
  • FEI: 2027158
Add To Cart